Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients

NCT03610230 ·Status: TERMINATED ·Phase: NA

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

NCT01114217 ·Status: COMPLETED ·Phase: PHASE3

Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA)

NCT07014371 ·Status: RECRUITING ·Phase: NA

A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia

NCT04350606 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion

NCT03900715 ·Status: COMPLETED ·Phase: PHASE2

A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia

NCT01114204 ·Status: COMPLETED ·Phase: PHASE3

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

NCT00145652 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia

NCT04899661 ·Status: ACTIVE_NOT_RECRUITING

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

NCT02453334 ·Status: COMPLETED ·Phase: PHASE3

A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects

NCT01030315 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes

NCT05719376 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

NCT03485053 ·Status: TERMINATED ·Phase: PHASE2

Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome

NCT01546337 ·Status: TERMINATED

Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients

NCT06830941 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia

NCT06080555 ·Status: COMPLETED ·Phase: PHASE1

Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia

NCT04309669 ·Status: COMPLETED ·Phase: PHASE4

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

NCT00721188 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

NCT00631163 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects

NCT02348372 ·Status: COMPLETED ·Phase: PHASE1

Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD

NCT03903809 ·Status: UNKNOWN ·Phase: PHASE3

Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients

NCT06556134 ·Status: COMPLETED ·Phase: PHASE4

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients

NCT00233597 ·Status: COMPLETED ·Phase: PHASE3

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

NCT00994318 ·Status: COMPLETED ·Phase: PHASE3

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

NCT00223977 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Iron Therapy in Patients With End-Stage Renal Disease

NCT04491916 ·Status: UNKNOWN ·Phase: NA